SPY458.79+5.37 1.18%
DIA352.82+6.58 1.90%
IXIC15,225.15+139.68 0.93%

HC Wainwright & Co. Maintains Buy on Zentalis Pharmaceuticals, Raises Price Target to $120

HC Wainwright & Co. analyst Andrew Fein maintains Zentalis Pharmaceuticals (NASDAQ:ZNTL) with a Buy and raises the price target from $80 to $120.

Benzinga · 11/11/2021 06:17
HC Wainwright & Co. analyst Andrew Fein maintains Zentalis Pharmaceuticals (NASDAQ:ZNTL) with a Buy and raises the price target from $80 to $120.